Proteomics in Transition: From Discovery to Diagnostic Relevance Whitepaper
/in Quanterix/by Harshita SharmaProteomics in Transition: From Discovery to Diagnostic Relevance Whitepaper
For years, discovery proteomics uncovered hundreds of candidate biomarkers — but most stalled before reaching the clinic. New digital platforms change that: they deliver femtogram-level sensitivity, reproducible quantification across sites, and the analytical rigor required for regulatory and clinical use.
Why this matters
Proteins reflect real-time biology. That means faster detection, better trial enrollment, and clearer measures of therapeutic effect. Whether you’re developing a diagnostic, designing an adaptive trial, or building a multi-omics model, the right proteomic data reduces guesswork and accelerates decisions.
Unlock with quick sign up!

Dr. Ebru Boslem
ANZ Market Manager - Research Genomics
As the official distributor in Australia and New Zealand, Decode Science makes accessing genomics solutions straightforward. Our role is to connect your lab with advanced technologies, ensuring you get the right solution for your sequencing projects—delivered locally with support when you need it.

















